These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 8805801)

  • 1. Role of the sympathetic nervous system in the ischemic and reperfused heart.
    Hara A; Abiko Y
    EXS; 1996; 76():285-97. PubMed ID: 8805801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-adrenoceptor stimulation-mediated preconditioning-like cardioprotection in perfused rat hearts.
    Nasa Y; Yabe K; Takeo S
    J Cardiovasc Pharmacol; 1997 Apr; 29(4):436-43. PubMed ID: 9156351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preconditioning does not prevent postischemic dysfunction in aging heart.
    Abete P; Ferrara N; Cioppa A; Ferrara P; Bianco S; Calabrese C; Cacciatore F; Longobardi G; Rengo F
    J Am Coll Cardiol; 1996 Jun; 27(7):1777-86. PubMed ID: 8636568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles of kappa opioid receptors in cardioprotection against ischemia: the signaling mechanisms.
    Wong TM; Wu S
    Sheng Li Xue Bao; 2003 Apr; 55(2):115-20. PubMed ID: 12715097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sympatho-adrenergic activation of the ischemic myocardium and its arrhythmogenic impact.
    Schömig A; Richardt G; Kurz T
    Herz; 1995 Jun; 20(3):169-86. PubMed ID: 7635399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha 1-adrenergic receptor-mediated increase in the mass of phosphatidic acid and 1,2-diacylglycerol in ischemic rat heart.
    Kurz T; Schneider I; Tölg R; Richardt G
    Cardiovasc Res; 1999 Apr; 42(1):48-56. PubMed ID: 10434995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Myocardial reperfusion: salvation or danger for the heart muscle? Stunning, hibernation and preconditioning: the states of endogenous cardiac protection against ischemia].
    Atar D
    Schweiz Med Wochenschr; 1997 Nov; 127(48):2008-13. PubMed ID: 9490468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The sympathetic nervous system and ischaemic heart disease.
    Remme WJ
    Eur Heart J; 1998 Jun; 19 Suppl F():F62-71. PubMed ID: 9651738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preconditioning modulates susceptibility to ischemia-induced arrhythmias in the rat heart: the role of alpha-adrenergic stimulation and K(ATP) channels.
    Ravingerová T; Pancza D; Ziegelhoffer A; Styk J
    Physiol Res; 2002; 51(2):109-19. PubMed ID: 12108920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Role of norepinephrine in myocardial ischemia and ischemic preconditioning].
    Naumenko SE; Gilinskiĭ MA
    Usp Fiziol Nauk; 2009; 40(2):26-39. PubMed ID: 19505021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenosine inhibits norepinephrine release in the postischemic rat heart: the mechanism of neuronal stunning.
    Burgdorf C; Richardt D; Kurz T; Seyfarth M; Jain D; Katus HA; Richardt G
    Cardiovasc Res; 2001 Mar; 49(4):713-20. PubMed ID: 11230970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Consequences of brief ischemia: stunning, preconditioning, and their clinical implications: part 1.
    Kloner RA; Jennings RB
    Circulation; 2001 Dec; 104(24):2981-9. PubMed ID: 11739316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of metoprolol and carvedilol pharmacology and cardioprotection in rabbit ischemia and reperfusion model.
    Feuerstein G; Liu GL; Yue TL; Cheng HY; Hieble JP; Arch JR; Ruffolo RR; Ma XL
    Eur J Pharmacol; 1998 Jun; 351(3):341-50. PubMed ID: 9721026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction between Na+/phosphate-cotransporter and the adrenoceptors in myocardial depression.
    Onwochei MO; Ofori AO; Agodoa IL
    J Cardiovasc Pharmacol; 1998 Jan; 31(1):10-7. PubMed ID: 9456271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prejunctional adrenergic receptors and sympathetic neurotransmission: studies in canine skeletal muscle vasculature in situ.
    Kahan T
    Acta Physiol Scand Suppl; 1987; 560():1-38. PubMed ID: 2884804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical and cellular implications of stunning, hibernation, and preconditioning: an NHLBI workshop.
    Kloner RA; Bolli R; Marban E; Reinlib L; Braunwald E
    Circulation; 1998 May; 97(18):1848-67. PubMed ID: 9603540
    [No Abstract]   [Full Text] [Related]  

  • 17. Stunning, preconditioning, and functional recovery after global myocardial ischemia.
    Bolling SF; Olszanski DA; Childs KF; Gallagher KP; Ning XH
    Ann Thorac Surg; 1994 Sep; 58(3):822-7. PubMed ID: 7944710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of beta 1- and beta 2-adrenoceptor subtypes in preconditioning against myocardial dysfunction after ischemia and reperfusion.
    Frances C; Nazeyrollas P; Prevost A; Moreau F; Pisani J; Davani S; Kantelip JP; Millart H
    J Cardiovasc Pharmacol; 2003 Mar; 41(3):396-405. PubMed ID: 12605018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protecting the myocardium from ischemic injury: a critical role for alpha(1)-adrenoreceptors?
    Salvi S
    Chest; 2001 Apr; 119(4):1242-9. PubMed ID: 11296192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hibernation, stunning, ischemic preconditioning--new paradigms in coronary disease?].
    Heusch G
    Z Kardiol; 1992 Nov; 81(11):596-609. PubMed ID: 1471397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.